Idéal Investisseur
Français English
CAC 40 : Market closed
8 065,02 pts
-1.49%


Last updated : 18/09/2026 - 17h35
🏠 Home   ➤    Stock news

EssilorLuxottica Stock at Lowest Level Since 2022, RSI in Oversold Territory at 26

EssilorLuxottica breaks a new record low on Friday unseen since 2022, deepening its decline in an already downward-trending CAC 40. The stock now trades at nearly half its value erased over one year, in a context of rising rates from major central banks that weighs on consumer discretionary stocks.


EssilorLuxottica Stock at Lowest Level Since 2022, RSI in Oversold Territory at 26

A Four-Year Low Breached in a Market Under Rate Pressure

EssilorLuxottica touched 138.70 € during trading on Friday, crushing the previous low of 138.85 € set in 2022, the year of the Ukraine war and sharp rate hikes. The stock declined 1.2% compared to Thursday's close at 141.45 €, bringing the one-year loss to nearly 48%. Over one month, the decline reaches 12.55%, reflecting a deterioration that has accelerated throughout the summer.

This new historic low occurs as the Bank of Japan raised its policy rate today to 1.25%, the highest level since 1995, and the Fed initiated its own rate hike this week. This context of coordinated central bank tightening intensifies pressure on valuation multiples for discretionary consumer stocks, a category to which the Franco-Italian optician belongs. The CAC 40 declines 0.76% during trading, but EssilorLuxottica underperforms the index with a 1.2% decline.

Solid Fundamentals, But Moving Averages Have Become Distant Resistance Levels

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

In terms of results, the group had published on July 28, 2026 a first half deemed solid, with adjusted operating income up 15% at constant exchange rates and free cash flow of 1.07 billion euros, up 100 million euros. Management had expressed confidence at the time, citing growth "near double-digit" and a better position than ever to accelerate the next phase of development. However, these fundamentals are insufficient to halt the stock's decline, which the technical configuration illustrates unequivocally: the stock trades at 139.75 € during the session, or 8.95% below its 20-day moving average at 153.49 €, and 13.5% below its 50-day moving average at 161.57 €. The 200-day moving average, at 203.71 €, is now more than 31% above the current price, a gap that signals the magnitude of the slippage accumulated over several months.

The RSI at 26 indicates a clear oversold configuration, extending the one already observed during last week's decline. The nearest resistance is located at 172.30 €, or more than 23% above the current price, which measures the distance to travel before any return to structural upward momentum. The analysts' consensus will need to be monitored following this further deterioration in the stock price.



Sector Dispositifs médicaux et optique Optique / lunetterie


Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext

Context

Period
  • Period: T2 2026
Key reported figures
  • Revenue: 7 692 millions d'euros
  • Quarterly revenue: 7 692 millions d'euros
  • Revenue growth: 7,2 %
Risks mentioned
  • Effets de change défavorables : croissance publiée inférieure à celle à taux de change constants
  • Dépendance à quelques moteurs de croissance (myopie, wearables IA) pour soutenir le rythme
  • Croissance modérée d'environ 5 % des activités historiques montures et santé visuelle
Opportunities identified
  • Solutions de gestion de la myopie en hausse de 24 % au T2, moteur de croissance confirmé
  • Chiffre d'affaires des lunettes IA quasiment doublé au T2 avec Ray-Ban et Oakley
  • Croissance à deux chiffres en Asie-Pacifique

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours